Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524743 | NSE Symbol : | ISIN : INE771F01025 | Industry : Trading |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
18-Feb-2025	18-Feb-2025	Preferential Issue	Fischer Medical ventures Limited(Formerly known as Fischer Chemic Limited) as informed the exchange on the outcome of Board meeting held on 18-02-2025 relating to allotment of equity shares and warrants through preferential issue.
07-Feb-2025	14-Feb-2025	Quarterly Results	Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve Unaudited Financial results for the quarter ended 31.12.2024 and other incidental business matters
28-Dec-2024	03-Jan-2025	EGM	Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/01/2025 inter alia to consider and approve 1. The withdrawal of the proposed preferential issue which was announced by the Company on December 26 2024; 2. The proposal for fund raising by way of preferential issue / private placement of securities for cash / other than cash including determination of Issue Price subject to such regulatory/statutory approvals as may be required including the approval of shareholders of the Company.; 3. The day date time and venue for Extra-Ordinary General Meeting of the Company; 4. The notice for Extra-Ordinary General Meeting (EOGM) of the Company; 5. To fix the date for book closure (Register of Member); 6. To appoint Mr. Nuren Lodaya Practicing Company Secretary (Membership No. 60128) proprietor of M/s. Nuren Lodaya & Associates. as Scrutinizer for conducting e-voting and poll process for General Meeting of the Company; 7. To transact other incidental and ancillary matters as may be decided by the Board with the permission of Chairperson. Outcome of Board Meeting is enclosed herewith (As Per BSE Announcement Dated on: 03/01/2025)
05-Nov-2024	13-Nov-2024	Quarterly Results	Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Unaudited Standalone and Consolidated results for the quarter and half year ended 30.09.2024 and any other business matters OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on 14.11.2024)
09-Aug-2024	14-Aug-2024	Preferential Issue	Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited standalone and consolidated Financial results for the period ended 30/06/2024 and also to consider fund raising through preferential issue for cash and non-cash consideration UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30.06.2024 (As Per BSE Announcement dated on 14.08.2024) Revised outcome with respect to typography error in the Annexure 2 relating to preferential issue without any change in the financial figures (As Per BSE Announcement dated on 15.08.2024) Revised outcome (As Per BSE Announcement Dated on 15.10.2024)
21-May-2024	30-May-2024	Accounts	FISCHER CHEMIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve audited Standalone and Consolidated Financial Results for the year and quarter ended 31.03.2024 Fischer Medical Ventures Limited (Formerly known as Fischer Chemic Limited) has informed the exchange on the approval of audited Standalone and Consolidated Financial Results for the quarter and year ended on 31.03.2024 Fischer Medical Ventures Limited (formerly known as Fischer Chemic Ltd) has informed the exchange on the approval of Board of Directors of the Company the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31.03.2024 (As Per BSE Announcement dated on 30.05.2024) Revised outcome (As per BSE Announcement Dated on 10/09/2024)
30-Apr-2024	04-May-2024	Others	FISCHER CHEMIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2024 inter alia to consider and approve 1. The Change in management of the Company subsequent to completion of open offer in accordance with the provisions of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011; 2. The setting up of corporate office Address of the Company in Chennai Tamil Nadu; and 3. To transact other incidental and ancillary matters as may be decided by the board We would like to inform you that the meeting of the Board of Directors of Fischer Medical Ventures Limited (Formerly known as Fischer Chemic Limited) was held on Saturday 04th May 2024 at the Registered Office of the Company. The outcome is enclosed herewith (As Per BSE Announcement dated on 04.05.2024)
19-Mar-2024	19-Mar-2024	Others	Please find enclosed outcome of separate meeting of independent diretcor
05-Feb-2024	12-Feb-2024	Quarterly Results	FISCHER CHEMIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve inter-alia amongst other matters the Un-Audited Standalone Financial Results along with the Limited Review Report for the quarter and nine months period ended 31st December 2023 We would like to inform you that the Board of Directors of Fischer Chemic Limited ('the Company') in its meeting held at the Registered Office of the Company on Monday, 12th February 2024 have approved the Un-audited standalone Financial Results of the Company for the Quarter and nine months ended December 31, 2023 pursuant to Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Financial results for quarter ended 31.12.2023 (As per BSE Announcement Dated on 12/02/2024)
25-Jan-2024	25-Jan-2024	Preferential Issue	The Board of Directors have considered and approved the allotment of securities.
12-Dec-2023	15-Dec-2023	Raising funds through Debt Instr.	FISCHER CHEMIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/12/2023 inter alia to consider and approve 1. The proposal for fund raising by way of preferential issue / private placement of securities for cash / other than cash including determination of Issue Price subject to such regulatory/statutory approvals as may be required including the approval of shareholders of the Company.; & 2. To transact other incidental and ancillary matters as may be decided by the board. FISCHER CHEMIC LTD has informed BSE about Board Meeting to be held on 15 Dec 2023 to consider Fund raising / Increase in authorised capital / Other business. In terms of Regulation 30 of SEBI LODR Regulations 2015 please find enclosed outcome of the Board Meeting held on 15th December 2023 for your knowledge and information. (As per BSE Announcement Dated on 15/12/2023)
24-Oct-2023	01-Nov-2023	Quarterly Results	FISCHER CHEMIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 ,inter alia, to consider and approve 1. Unaudited financial result for the second quarter and half year ended on September 30, 2023 along with the Auditor''s Limited Review Report.; & 2. Any other business with the permission of Chairman. FISCHER CHEMIC LTD. has informed BSE about Board Meeting to be held on 01 Nov 2023 to consider financial statements for the period ended September 2023. Financial results. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR'), this is to inform you that the Company's Board of Directors, at their Meeting held on today i.e., November 01, 2023 have inter-alia considered and approved the un-audited Financial Results of the Company for the quarter and half year ended on 30th September, 2023. Further, in terms of the provisions of Regulation 33 of the SEBI LODR, enclosed herewith please find enclosed the Un-audited Financial Results for the quarter and half year ended on 30th September, 2023 and Limited Review report of Statutory Auditors for the quarter and half year ended on 30th September, 2023. Financial Results for the Quarter & six months ended 30th September 2023 (As per BSE Announcement Dated on 01/11/2023)
28-Aug-2023	28-Aug-2023	AGM	Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of our Company was held today i.e., on Monday 28th August 2023 at the Registered Office and the Board has considered and approved the notice and Board Report for the financial year ended 31st March 2023.
02-Aug-2023	12-Aug-2023	Quarterly Results	FISCHER CHEMIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve 1-To consider and approve the Unaudited Standalone Financial Results of the Company for the quarter ended 30th June 2023; 2-To take on records the Auditors Limited Review Report on Un-audited Financial Results of the Company the quarter ended 30th June 2023; 3-Any other business matters with the permission of the chairperson. News paper publication of financial results for the quarter ended 30th June 2023. (As Per BSE Announcement Dated on 14.08.2023)
29-Jun-2023	29-Jun-2023	Preferential Issue	Disclosure under Regulation 30 of SEBI LODR Regulations 2015-Allotment of Equity Shares.

1 2 3

LOGIN HERE

Fischer Medical Ventures Ltd

Board Meeting